Nutra News made Easy
Low-glycemic carbohydrate isomaltulose (ISO) supports incretin release and improves postprandial control via the second meal effect (SME), relevant for metabolic syndrome (MetS). In a randomized crossover trial, 15 MetS subjects received ISO or sucrose (SUC) preloads 1 h or 3 h before a test meal. ISO blunted glucose rise (ΔG/Δt: 0.28 vs. 0.53 mmol/L/min, p<0.01),… Read More
The recent study on a compound called Dehydroeburicoic Acid (DEA), a triterpenoid found in the fungus Antrodia cinnamomea. It identifies DEA as a potential therapeutic agent for Alcoholic Liver Disease (ALD). The research reveals that DEA acts as a dual inhibitor,uniquely targeting two key cellular pathways: the Keap1-Nrf2 protein-protein interaction (PPI) and glycogen synthase kinase… Read More
The Delicens2021 study investigated the safety of combining whey protein (20 g) with pomegranate extract (650 mg) in adults aged ≥65 years. Conducted as a 21-day randomized, double-blind, placebo-controlled clinical trial, it compared a protein–maltodextrin control with the protein–pomegranate group. Results demonstrated that supplementation was safe and well-tolerated, with no adverse events or significant abnormalities… Read More
The clinical study on Biotical™ GH adds meaningful evidence to the emerging science of the gut–hair axis. By running a 24-week, randomized, placebo-controlled trial, researchers were able to show not just improvements in hair density, but also measurable shifts in the scalp microbiome. This is important because the scalp environment plays a critical role in… Read More
A 12-week randomized trial explored how palmitoylethanolamide (PEA) affects the gut microbiome and health markers in overweight adults (n=58, BMI 30–40). Participants received either PEA (n=36) or placebo (n=22). PEA supplementation significantly lowered serum triglycerides and IL-2 levels. Gut microbiota composition, richness, and diversity showed no major group differences, but pathway analysis revealed targeted effects:… Read More